| [Download PDF]
|Year : 2004 | Volume
| Issue : 2 | Page : 127-
Department of Pharmacology, JIPMER, Pondicherry - 605006, India
D G Shewade
Department of Pharmacology, JIPMER, Pondicherry - 605006
|How to cite this article:|
Shewade D G. Book Review.Indian J Pharmacol 2004;36:127-127
|How to cite this URL:|
Shewade D G. Book Review. Indian J Pharmacol [serial online] 2004 [cited 2021 Mar 8 ];36:127-127
Available from: https://www.ijp-online.com/text.asp?2004/36/2/127/6780
Chhattisgarh State Drug Formulary - 2003: Edited by Kaul S, Sunderaraman T, Shastri S and Singh PD. Published by the Department of Health & Family Welfare, Government of Chhattisgarh, Raipur, Pages 381.
A drug formulary provides appropriate information about medicines, ensures their proper use and decreases the inappropriate use of medicines. The Health Ministry of the newly carved state of Chhattisgarh has fulfilled its responsibility in this regard. Its Drug Formulary is based on the WHO Model Formulary 2002, by altering the existing text or by aligning the WHO Model Formulary to their list of essential medicines. The changes suit their needs.
While editing the Formulary, medicines used only at the tertiary level have been deliberately left out indicating that the Formulary is meant for primary or at the most secondary level of health care. Appendices covering drug interaction, safety during pregnancy and breast-feeding have been retained but the effect of renal and hepatic impairment on drugs has been dropped. However, some useful additional topics like rational drug therapy, variation in dose response, compliance, adverse drug reaction (ADR) and prescription writing have been included. The ADR reporting form should have been included.
The Formulary is of pocket size and hence it is easy to carry. The format and information provided are appropriate. Certain typographical errors have gone unnoticed while proofreading. Further, certain drugs which are not in common use have been included, e.g. propylthiouracil, salbutamol injection, and meglumine iotroxate, while certain commonly used drugs like pentazocine, carbimazole, and parenteral NSAID have been left out. These defects can be eliminated via effective feedback from the users. Cost-effectiveness analysis from time to time can further refine and improve the next edition of the Formulary.
Standard clinical guidelines for common diseases combined with appropriate education and training programs aimed at encouraging drug formulary use are required for rational drug therapy. It is hoped that the Formulary will be updated at regular intervals and that the state health care providers will adhere to it for its success.